Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Nelson

Showing results (41-50 of 448) with videos related to

Pageof 45
Sort By:
Gene|July 26, 2002
Isolation and characterization of the murine prostate short-chain dehydrogenase/reductase 1 (Psdr1) gene, a new member of the short-chain steroid dehydrogenase/reductase familyStacy Moore, Colin Pritchard, Biaoyang Lin, et al.
Cancer Genetics|March 21, 2020
Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGENXiaoyu Qu, Cecilia Yeung, Ilsa Coleman, et al.
Molecular and Cellular Biology|January 24, 2006
Phenotypic analysis of mice lacking the Tmprss2-encoded proteaseTom S Kim, Cynthia Heinlein, Robert C Hackman, et al.
Genome Biology|April 6, 2006
The contributions of normal variation and genetic background to mammalian gene expressionColin Pritchard, David Coil, Sarah Hawley, et al.
The Prostate|June 4, 2004
Characterization and comparative analyses of transcriptomes from the normal and neoplastic human prostateNigel Clegg, Denise Abbott, Camari Ferguson, et al.
The Prostate|January 30, 2002
Human prostate epithelial cell-type cDNA libraries and prostate expression patternsAlvin Y Liu, Peter S Nelson, Ger van den Engh, et al.
Advances in Anatomic Pathology|December 1, 2007
The role of tissue microarrays in prostate cancer biomarker discoveryMilton W Datta, Lawrence D True, Peter S Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Two Steps Forward and One Step Back for Precision in Prostate Cancer TreatmentMichael T Schweizer, Heather H Cheng, Peter S Nelson, et al.
BMC Cancer|June 1, 2010
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancerBruce Montgomery, Peter S Nelson, Robert Vessella, et al.
Oncogene|August 13, 2002
Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivoAchim Aigner, Heiner Renneberg, Jörg Bojunga, et al.
Pageof 45

Showing results (41-50 of 448) with videos related to

Sort By:
Pageof 45
Gene|July 26, 2002
Isolation and characterization of the murine prostate short-chain dehydrogenase/reductase 1 (Psdr1) gene, a new member of the short-chain steroid dehydrogenase/reductase familyStacy Moore, Colin Pritchard, Biaoyang Lin, et al.
Cancer Genetics|March 21, 2020
Comparison of four next generation sequencing platforms for fusion detection: Oncomine by ThermoFisher, AmpliSeq by illumina, FusionPlex by ArcherDX, and QIAseq by QIAGENXiaoyu Qu, Cecilia Yeung, Ilsa Coleman, et al.
Molecular and Cellular Biology|January 24, 2006
Phenotypic analysis of mice lacking the Tmprss2-encoded proteaseTom S Kim, Cynthia Heinlein, Robert C Hackman, et al.
Genome Biology|April 6, 2006
The contributions of normal variation and genetic background to mammalian gene expressionColin Pritchard, David Coil, Sarah Hawley, et al.
The Prostate|June 4, 2004
Characterization and comparative analyses of transcriptomes from the normal and neoplastic human prostateNigel Clegg, Denise Abbott, Camari Ferguson, et al.
The Prostate|January 30, 2002
Human prostate epithelial cell-type cDNA libraries and prostate expression patternsAlvin Y Liu, Peter S Nelson, Ger van den Engh, et al.
Advances in Anatomic Pathology|December 1, 2007
The role of tissue microarrays in prostate cancer biomarker discoveryMilton W Datta, Lawrence D True, Peter S Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Two Steps Forward and One Step Back for Precision in Prostate Cancer TreatmentMichael T Schweizer, Heather H Cheng, Peter S Nelson, et al.
BMC Cancer|June 1, 2010
Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancerBruce Montgomery, Peter S Nelson, Robert Vessella, et al.
Oncogene|August 13, 2002
Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivoAchim Aigner, Heiner Renneberg, Jörg Bojunga, et al.
Pageof 45